DEA schedule
Is dihydroergotamine a controlled substance?
Federal schedule for dihydroergotamine from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Dihydroergotamine is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and dihydroergotamine is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted dihydroergotamine?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 15 prescription listings from 13 labelers, none with a DEA schedule |
| DEA controlled substances list | dihydroergotamine is not on the list |
Dihydroergotamine NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 76978-101 | ATZUMI | powder | 5.2 mg/1 | Satsuma Pharmaceuticals, Inc. | None |
| 64896-509 | BREKIYA | injection | 1 mg/mL | Amneal Pharmaceuticals LLC | None |
| 77530-725 | Trudhesa | spray, metered | 4 mg/mL | Impel Pharmaceuticals LLC | None |
| 0143-9151 | Dihydroergotamine Mesylate | injection | 1 mg/mL | Hikma Pharmaceuticals USA Inc. | None |
| 0143-9273 | Dihydroergotamine Mesylate | injection | 1 mg/mL | Hikma Pharmaceuticals USA Inc. | None |
| 68083-466 | Dihydroergotamine Mesylate | injection | 1 mg/mL | Gland Pharma Limited | None |
| 36000-300 | dihydroergotamine mesylate | injection, solution | 1 mg/mL | Baxter Healthcare Corporation | None |
| 71357-013 | Dihydroergotamine Mesylate | injection, solution | 1 mg/mL | Milla Pharmaceuticals Inc. | None |
| 81284-411 | Dihydroergotamine Mesylate | injection, solution | 1 mg/mL | Provepharm Inc. | None |
| 24201-463 | Dihydroergotamine Mesylate | spray | 4 mg/mL | Hikma Pharmaceuticals USA Inc. | None |
| 68682-357 | Dihydroergotamine Mesylate | spray | 4 mg/mL | Oceanside Pharmaceuticals | None |
| 72888-096 | Dihydroergotamine mesylate | spray | 4 mg/mL | Advagen Pharma Ltd | None |
| 73352-096 | Dihydroergotamine mesylate | spray | 4 mg/mL | Trifluent Pharma, LLC | None |
| 70069-880 | DIHYDROERGOTAMINE MESYLATE | spray, metered | 4 mg/mL | Somerset Therapeutics, LLC | None |
| 69097-503 | Dihydroergotamine Mesylate Nasal | spray, metered | 4 mg/mL | Cipla USA Inc. | None |
Questions
Is dihydroergotamine a controlled substance?
No. Dihydroergotamine is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and dihydroergotamine is not on the DEA controlled substances list.
Is dihydroergotamine a narcotic?
No. Dihydroergotamine is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Ergotamine Derivative.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Dihydroergotamine
- What is Dihydroergotamine used for?FDA label uses
- Generic for D.h.e.FDA Orange Book
- Generic for AtzumiFDA Orange Book
- Generic for Brekiya (autoinjector)FDA Orange Book
- Generic for MigranalFDA Orange Book
- Generic for TrudhesaFDA Orange Book
- Ergotamine Derivatives listFDA drug class
- NDC 64896-509Dihydroergotamine NDC record
- NDC 76978-101Dihydroergotamine NDC record
- NDC 77530-725Dihydroergotamine NDC record